Skip to content

IEMbase 0282: DNM1L-related Dynamin-like protein 1 deficiency

Scope

Field Value
IEMbase ID 282
Nosology 19.2.01.01
Gene DNM1L
External IDs OMIM:614388; ORPHA:98673
Generated mapping UNMAPPED; weak candidate Pyruvate_Dehydrogenase_Deficiency.yaml
Candidate DisMech targets None valid
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents DNM1L-related defective mitochondrial and peroxisomal fission encephalopathy. The alternate label in the cache is "Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission" with the spelling preserved from IEMbase. Inheritance is listed as autosomal dominant and autosomal recessive. Treatability is unknown.

The phenotype signal is a severe early neurologic disorder: neonatal abnormal gyral pattern, delayed myelination, hypotonia, microcephaly, muscle weakness, areflexia, optic atrophy, failure to thrive, later cerebral atrophy, oculomotor apraxia, psychomotor delay, pyramidal signs, neurologic regression, and seizures. The biochemical rows list increased plasma lactate and increased plasma very-long-chain fatty acids.

DisMech phenotype coverage

There is no local DisMech disease entry for DNM1L-related mitochondrial and peroxisomal fission defect. Repository search finds DNM1L mentioned only as context in unrelated entries such as obesity, while other dynamin-family or mitochondrial-dynamics entries involve different genes and disease entities.

The generated weak candidate, Pyruvate_Dehydrogenase_Deficiency.yaml, is not a valid target. PDH deficiency can share lactic acidosis and neurologic features, but it does not model the DNM1L/DRP1 fission mechanism, the combined mitochondrial-peroxisomal dynamics defect, or the associated VLCFA abnormality.

Concordance and completeness

Judgement: true local gap; do not map to the weak PDH candidate.

IEMbase provides a compact but coherent DNM1L phenotype profile centered on early encephalopathy, abnormal brain development/myelination, optic atrophy, regression, seizures, hypotonia, lactate elevation, and VLCFA elevation. DisMech currently lacks a corresponding disease-level entry, and the existing mitochondrial/peroxisomal entries do not cover this fission-dynamics disorder.

This is a useful future curation target because it crosses organelle biogenesis/dynamics and peroxisomal metabolic readouts. Any future entry should distinguish DNM1L from MFF and other mitochondrial fission genes, and should separate primary fission biology from secondary lactic acidosis or peroxisomal fatty-acid abnormalities.

Curation actions

  • Leave this record unmapped for now.
  • Reject Pyruvate_Dehydrogenase_Deficiency.yaml as a false-positive metabolic encephalopathy candidate.
  • Consider a future standalone DNM1L entry or a mitochondrial/peroxisomal dynamics grouping that can also accommodate later MFF-related records.